Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer.
Journal: JAMA network open
Published: April 10, 2026
Effect of Donepezil on Dimensions of Patient-Reported Cognitive Impairment in Breast Cancer Survivors: Secondary Analysis of the NCORP REMEMBER Trial (WF-97116).
Journal: JCO oncology advances
Published: January 01, 2025
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study.
Journal: Cancers
Published: November 27, 2024
Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment.
Journal: NEJM evidence
Published: March 13, 2023
Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy.
Journal: Seminars in oncology nursing
Published: October 05, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
Journal: Journal for immunotherapy of cancer
Published: November 16, 2021
Use of vemurafenib in anaplastic thyroid carcinoma: a case report.
Journal: Cancer biology & therapy
Published: July 16, 2015
Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: October 29, 2013
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Journal: The oncologist
Published: September 28, 2013
A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer.
Journal: American journal of clinical oncology
Published: December 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026